News

Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
How alterations in cell metabolism translate into specific developmental gene programs remains a major question. This study ...
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Removing EPO signaling in mouse liver tumors leads to tumor regression along with sensitivity to immunotherapy.
Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...